Journal Guide

Preparative Biochemistry & Biotechnology is an international forum for rapid dissemination of high-quality research results dealing with all aspects of preparative techniques in biochemistry, biotechnology, and other life science disciplines that are pertinent to clarification, isolation, enrichment, and purification of biotech products. These products could be in the areas of human therapeutics, biofuels, plant biotechnology, animal biotechnology, food processing, and environmental biotechnology. Unit operations may include fermentation/cell culture, centrifugation, depth filtration, homogenization, chromatography, ultrafiltration, diafiltration, refolding, viral filtration, viral inactivation, sterile filtration, extraction, two phase separation, precipitation, osmotic shock, lyophilization, and other process steps that are utilized in manufacturing of the above mentioned products. Priority will be given to novel results that are likely to have major impact on the respective research area. Readership Readership includes chemists, biotechnologists, engineers, physicists and life scientists involved in discovery, development or manufacturing of products in the areas of human therapeutics, biofuels, plant biotechnology, animal biotechnology, food processing and environmental biotechnology. Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.

Prevention sciences encompassing etiology, epidemiology and intervention are represented through peer-reviewed original research articles on a variety of health and social problems, including but not limited to substance abuse, mental health, HIV/AIDS, violence, accidents, teenage pregnancy, suicide, delinquency, STD's, obesity, diet/nutrition, exercise, and chronic illness. The journal also publishes literature reviews, theoretical articles, and papers concerning new developments in methodology.Prevention Science is the official publication of the Society for Prevention Research.

Founded in 1972 by Ernst Wynder, Preventive Medicine is an international scholarly journal that provides prompt publication of original articles on the science and practice of disease prevention, health promotion, and public health policymaking. Preventive Medicine aims to reward innovation. It will favor insightful observational studies, thoughtful explorations of health data, unsuspected new angles for existing hypotheses, robust randomized controlled trials, and impartial systematic reviews. Preventive Medicine's ultimate goal is to publish research that will have an impact on the work of practitioners of disease prevention and health promotion, as well as of related disciplines.

Preventive Medicine Reports is the sister journal to http://www.journals.elsevier.com/preventive-medicinePreventive Medicine, the well-established medical journal founded by Ernst Wynder in 1972.

The journal publishes original research articles and high quality reviews in the fields of clinical care, diabetes education, nutrition, health services, psychosocial research and epidemiology and other areas as far as is relevant for diabetology in a primary-care setting. The purpose of the journal is to encourage interdisciplinary research and discussion between all those who are involved in primary diabetes care on an international level. The Journal also publishes news and articles concerning the policies and activities of Primary Care Diabetes Europe and reflects the society's aim of improving the care for people with diabetes mellitus within the primary-care setting.Please visit http://www.primary-care-diabetes.com for free content.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Primary Care: Clinics in Office Practice updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each quarterly issue (March, June, September, and December) focuses on a single topic in primary care. Topics covered include allergy and immunology, cardiology, adolescent health, endocrinology, ENT, gastroenterology, geriatrics, hematology/oncology, infectious disease, gynecology and women's health, nephrology, neurology, orthopedics/sports medicine, pediatrics, preventive medicine, psychiatry, rheumatology, and urology.

Prion is the first international peer-reviewed journal to focus exclusively on protein folding and misfolding, protein assembly disorders, protein-based and structural inheritance. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The overriding criteria for publication in Prion are originality, scientific merit and general interest.Prion is a quarterly publication. Accepted manuscripts will be made available on the website immediately.

Conference proceedings are accepted for publication in Procedia in Vaccinology based on suitability and are required to meet certain criteria, including relevance to an international audience and covering highly cited or timely topics. Procedia in Vaccinology will cover proceedings in all topics related to vaccines and vaccination.

What does Procedia in Vaccinology offer authors and conferences organizers?
Procedia in Vaccinology offers a single, highly recognized platform where conference papers can be hosted and accessed by millions of researchers. Authors then know where to go to keep abreast of the latest developments in their field. All proceedings appear online, on Science Direct, within 8 weeks of acceptance of the final manuscripts via the conference organizer and are freely available to all users. Procedia in Vaccinology offers authors and conference organizers a fast and cost effective way to provide maximum exposure for their papers.

Word templates are provided to assist in the publication and the final online papers contain linked references, XML versions and DOI numbers.

Why should conference organizers choose Procedia in Vaccinology?
Unlike regular journals, there is no limit to the amount of papers a Procedia in Vaccinology issue can contain and pricing is affordable, clear and transparent. Procedia in Vaccinology offers immediate access for all, with papers online within 8 weeks of acceptance, and free access providing maximum exposure for individual papers and the related conference. Organizers are credited on the actual issue and are fully responsible for quality control, the review process and the content of individual conference papers.

What is the process for submitting conference proceedings to Procedia in Vaccinology?
Proposals, including a synopsis of why such a Procedia in Vaccinology issue will have an impact on its community, a list of agreed contributors and an outline of the related conference (including a link to the conference website) should be sent to:

Alina Helsloot
Executive Publisher
a.helsloot@elsevier.com

Proposals should be prepared using the template /inca/publications/misc/PROVAC Proposal Template.dochere.

Please note that we do not accept proposals from individual authors for Procedia titles.

What are the costs associated with Procedia in Vaccinology?
There is an agreed fee, based on the size of the proceedings, which includes online publication on http://www.sciencedirect.comScienceDirect and free access after acceptance. In addition to the online version there is the possibility to purchase paper copies, CD-ROMs and USB sticks. Moreover, interactive media possibilities such as webcasts and web seminars can be acquired for extra exposure both before and after the conference.

Can Procedia in Vaccinology be sponsored?
We are open to discussing sponsoring possibilities at all times. Sponsors can include funding bodies, government agencies and/or industry. Benefits to sponsors include visibility amongst a scientific audience and the opportunity to communicate messages via a peer-reviewed platform. Benefits to authors and conference organizers are the further dissemination of material to an international audience and reduced costs to the overall conference budget.